Alzheimer; News from the web:

The FDA has produced guidance to help researchers get approval for certain types of projects.

FDA’s draft guidance may help researchers design clinical trials for early stage Alzheimer’s therapies. The agency hopes that the guidance will serve as a focus for continued discussions among FDA, sponsors of new drugs, the academic community, and the public.

Read all about it HERE